Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
Key facts
- Who runs it
- University Hospital, Geneva
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 320 people enrolled
- Started
- 10 Jan 2023
- Ended
- 31 Dec 2024
- Type of study
- Observational
- Record updated
- 14 January 2025
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- In general good health, as determined by study investigators
- All participants must be living in the canton of Geneva or working/studying in the canton of Geneva and living in neighboring communities that are within one hour travelling distance by car
Who cannot take part
- Treated with inhaled drugs by nasal route within the last month
- Inability to provide written consent
- Severely immunocompromised subjects as determined by the study investigator
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to learn about the influence of pre-existing mucosal immunity, i.e. antibodies and immune cells that are present at the nasal mucosa before infection, on the infectious viral load after infection with SARS-CoV-2, influenza virus and RSV. The investigators will include app. 320 participants which will be followed for up to 17 months. During this time, the investigators will monitor their nasal mucosal antibodies at regular intervals and compare them to their infectious viral load if they are infected with SARS-CoV-2, influenza virus or RSV. Participants are invited to take a test for SARS-CoV-2, influenza virus or RSV in case of respiratory symptoms. If participants are positive the investigators will follow their viral load kinetics by taking nasopharyngeal swabs every 2-3 days. The investigators will also record the duration and strength of the following symptoms:
Read full original descriptionShow less
* Cough * Fever * Tired * Sore throat * Difficulty breathing * Respiratory distress * Headache * Loss (or alteration) of smell * Loss (or alteration) of sense of taste * Myalgias * Chills * Subjective fever * Pink sputum (or coughing up blood) * Thoracic pain * Runny nose * Abdominal pain * Nausea * Vomiting * Diarrhea * Constipation * Irritated or watery eyes * Rashes * Other
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 14 January 2025